Should Investors Consider Sight Sciences Stock?
Sight Sciences (NASDAQ: SGHT) only recently made its public debut. Since the company's initial public offering last summer, shares have plunged by nearly 50%. Is this company, which markets medical devices to treat diseases of the eye, one that investors should put on their watch list right now?